The Clinical Research Of The Therapeutic Effect Of Acupuncture And Chinese Drugs In The Threatment Of Kidney Deficient Type Migranine

Migraine is a common, often recurrent refractory protracted neurologic illnesses. There is not yet a clear understangding of etiology, pathogenesis of migraine in Modern medicine, although Westren medicine has already carried on an in-depth study on it, but has not find out the miracle drug as yet. Even with ever-renewing medicine, but long-term effects is still unsatisfactory, and the side effects is not conducive to the promotion. WHO consides that migraine is a disease that is seriously harmful for human health and affects the quality of life.ObjectiveIn this study, we designed a randomized, controlled trial. To observed the clinical effect of acupuncture and Chinese drugs in the threatment of kidney deficient type migranine. The aim of this paper is to probe the mechanism of the treatment that strengthening and reducing rotaing needles combined Chinese medicine decoction Da Bu Yuan Jian for kidney deficient type migranine, and want to provide thinking and evidence for experiment study and clinical usage.Methodswe selected90insomnia patients who accepted treatment in TaiWan MingShi Traditional Chinese medicine clinic, duiring the period of2011/2to2012/3. we randomly divided the cases into three groups, a intergration therapeutics group,a strengthening and reducing rotaing needles group and a Chinese medicine group.30cases in each group. The intergration therapeutics group treated with acupuncture combined Chinese medicine decoction Da Bu Yuan Jian, and compared with the other two groups, A4weeks course of treatment, and then recorded the migranin symptom-sing scores, MSQ scores, SF-MPQ scores. We assessed the difference of the treatment effect of the three groups by SPSS software statistics. Results1according to migranin symptom-sing scores, the three groups before treatmen was no significant difference (P>0.05). After the treatment, the symptom-sing scores of the three groups were decreased. And the difference was significant (P<0.01). the multiple comparisons showed that, there was significant difference between A and B group, A and C groups (P<0.05). But B and C groups had no statistical significance (P>0.05). it showed that the intergration therapeutics group was more effective than the other two groups in decreasing the migranin symptom-sing scores.2according to migranin MSQ scores, The MSQ scale included three items: function limitation. Function obstacle and emotion, the three groups before treatmen was no significant difference (P>0.05). After the treatment, each item of the three groups were changed. And the difference was significant (P<0.05). the multiple comparisons showed that, there was significant difference between A and B group, A and C groups (P<0.01P<0.05). But B and C groups had no statistical significance (P>0.05). it showed that the intergration therapeutics group was supper to the other two groups in improving the MSQ scores.3according to the SF-MPQ scores, the three groups before treatmen was no significant difference (P>0.05). After the treatment, the symptom-sing scores of the three groups were decreased. And the difference was significant (P<0.01). the multiple comparisons showed that, there was significant difference between A and B group, A and C groups (P<0.05P<0.01). But B and C groups had no statistical significance (P>0.05). it showed that the intergration therapeutics group was more effective than the other two groups in decreasing the SF-MPQ scores.4the clinical efficacy, intergration therapeutics group, the clinical recovery was7, markedly effective3cases, effective7cases, inefficacy3cases, the effective rate was90.0%, while in other two groups, clinical recovery was4, markedly effective10cases, effective11cases, inefficacy5cases, the effective rate was83.3%, and clinical recovery was2, markedly effective10cases, effective10cases, inefficacy8cases, the effective rate was73.3%, the curative effect of the treatment group was better than others (P<0.05).Conclusion In the study, the treatment of strengthening and reducing rotaing needles combined Chinese medicine decoction Da Bu Yuan Jian for kidney deficient type migranine can effectively control attack times, lasting time and accompanied symptoms. And alleviate pain of patients, improve quality of life. Its method is simple, practical, safe and worthy of clinical use.